🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,760 results for “Pharm” Clear

  1. Solriamfetol

    Jazz Pharmaceuticals Ireland Limited

    Binge Eating Disorder

    approved small molecule active

    1 trial

  2. SomaKit TOC 40 micrograms kit for radiopharmaceutical preparation

    Ningbo Cancer Hospital

    Gastroenteropancreatic neuroendocrine tumors

    approved small molecule active

    1 trial

  3. Stent

    Rhythm Pharmaceuticals Netherlands B.V.

    Ischemic Heart Disease

    approved other completed

    1 trial

  4. Stereotactic Radiation Therapy

    GT Biopharma

    Glioblastoma

    approved other terminated

    1 trial

  5. Sulforaphane

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    HIV Infections

    approved small molecule active

    1 trial

  6. Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

    GT Biopharma

    Glioblastoma

    approved other active

    1 trial

  7. Suzetrigine

    Vertex Pharmaceuticals (Australia) Pty.

    Pain

    approved small molecule active

    6 trials

  8. Suzetrigine

    Vertex Pharmaceuticals (Australia) Pty.

    Acute Pain

    approved small molecule completed

    2 trials

  9. T-jet® containing TevTropin®

    Teva Pharma GmbH

    Growth Hormone Deficiency

    approved other completed

    1 trial

  10. TIMOFEROL 50 mg, comprimé enrobé, TIMOFEROL, gélule, FERRIC CARBOXYMALTOSE

    Pari Pharma GmbH

    Women who delivered by caesarean and have a moderate postpartum iron deficiency anaemia defined by 8.0 g/dL ≤ postoperative Hb level ≤ 10.0 g/dL within 72h after delivery and a ferritinemia ≤ 100 ng/mL OR transferrin saturation ≤ 20% (Measured after postoperative Hb level measurement)

    approved small molecule active

    1 trial

  11. TMT212, TMT212, Mekinist 0.5 mg film-coated tablets, Mekinist 2 mg film-coated tablets, DRB436, DRB436, DRB436, TMT212

    Novartis Pharmaceuticals

    Multiple indications

    approved small molecule active

    1 trial

  12. TPO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    ITP

    approved small molecule completed

    1 trial

  13. TRALOKINUMAB, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP.

    LEO Pharma A/S

    Atopic dermatitis and moderate-to severe atopic hand eczema

    approved small molecule active

    1 trial

  14. TYRX™ Absorbable Antibacterial Envelope

    Rhythm Pharmaceuticals Netherlands B.V.

    CIED Related Infection

    approved other completed

    1 trial

  15. Taneasy 600mg granules

    Biotech Pharmaceutical Co.,

    COPD (Chronic Obstructive Pulmonary Disease)

    approved small molecule completed

    1 trial

  16. Tantum Verde P 3 mg pastiglie gusto menta

    Lacuna Pharma Pty Ltd

    NON STREPTOCOCCAL PHARYNGOTONSILLITIS

    approved small molecule active

    1 trial

  17. Telaprevir

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    approved small molecule completed

    11 trials

  18. Telavancin

    Theravance Biopharma Ireland Umited

    End-Stage Renal Disease

    approved small molecule completed

    1 trial

  19. Telavancin Injection

    CUMBERLAND PHARMACEUTICALS INC

    Subarachnoid Hemorrhage, Aneurysmal

    approved small molecule active

    1 trial

  20. Telavancin Injection

    CUMBERLAND PHARMACEUTICALS INC

    Cystic Fibrosis

    approved small molecule completed

    1 trial

  21. The placebo MDI is formulated as a suspension of spray-dried porous particles (consisting of 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC] and calcium chloride) in a hydrofluoroalkane propellant (HFA-134a). The placebo MDI uses the same excipients as active product but with absence of the active pharmaceutical ingredient (API)., Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation, suspension

    AstraZeneca AB

    Chronic Obstructive Pulmonary Disease

    approved small molecule active

    1 trial

  22. The placebo has the same composition as the investigational medicinal product alkacitrat effervescent tablet 2 g/tab (with the exception of the active substance), is manufactured by the same manufacturer (uni-pharma kleon tsetis pharmaceutical laboratory s.a) and is not sterile., ALKACITRAT Αναβράζον δισκίο 2 g/tab

    Lacuna Pharma Pty Ltd

    Functional Dyspepsia

    approved small molecule active

    1 trial

  23. Ticagrelor followed with Methoxyflurane

    COLLEGIUM PHARMACEUTICAL, INC

    Unstable Angina

    approved small molecule completed

    1 trial

  24. Topiramate

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Alcohol Dependence

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources